These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 32860426)

  • 1. COVID-19 and nail manifestation: be on the lookout for the red half-moon nail sign.
    Méndez-Flores S; Zaladonis A; Valdes-Rodriguez R
    Int J Dermatol; 2020 Nov; 59(11):1414. PubMed ID: 32860426
    [No Abstract]   [Full Text] [Related]  

  • 2. The red half-moon nail sign: a novel manifestation of coronavirus infection.
    Neri I; Guglielmo A; Virdi A; Gaspari V; Starace M; Piraccini BM
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e663-e665. PubMed ID: 32535979
    [No Abstract]   [Full Text] [Related]  

  • 3. Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection?
    Diociaiuti A; Giancristoforo S; Terreri S; Corbeddu M; Concato C; Ciofi Degli Atti M; Zambruno G; Carsetti R; El Hachem M
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e10-e13. PubMed ID: 32920919
    [No Abstract]   [Full Text] [Related]  

  • 4. Onychomadesis following COVID-19 infection: Is there a relationship?
    Senturk N; Ozdemir H
    Dermatol Ther; 2020 Nov; 33(6):e14309. PubMed ID: 32935910
    [No Abstract]   [Full Text] [Related]  

  • 5. Beau's Lines and Leukonychia in a COVID-19 Patient.
    Ide S; Morioka S; Inada M; Ohmagari N
    Intern Med; 2020 Dec; 59(24):3259. PubMed ID: 33132338
    [No Abstract]   [Full Text] [Related]  

  • 6. Nail changes as manifestation of systemic disease in COVID-19 infection.
    Ocampo-Garza SS; Ocampo-Candiani J; Camela E; Vastarella M; Fabbrocini G; Scalvenzi M; Villani A
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e474-e475. PubMed ID: 33830556
    [No Abstract]   [Full Text] [Related]  

  • 7. The red half-moon nail sign: A new case report.
    Kammoun N; Kouki C; Hammami F; Sellami K; Rekik M; Bahloul E; Chtioui E; Amouri M; Masmoudi A; Turki H
    J Cosmet Dermatol; 2022 Oct; 21(10):5248-5249. PubMed ID: 35166013
    [No Abstract]   [Full Text] [Related]  

  • 8. Transverse leukonychia (Mees' lines) nail alterations in a COVID-19 patient.
    Fernandez-Nieto D; Jimenez-Cauhe J; Ortega-Quijano D; Diaz-Guimaraens B; Dominguez-Santas M; Martinez-Rubio J
    Dermatol Ther; 2020 Nov; 33(6):e13863. PubMed ID: 32779847
    [No Abstract]   [Full Text] [Related]  

  • 9. Nail Manifestations in COVID-19: Insight into a Systemic Viral Disease.
    Preda-Naumescu A; Penney K; Pearlman RL; Brodell RT; Daniel CR; Nahar VK
    Skin Appendage Disord; 2021 Aug; 183(6):1-6. PubMed ID: 34580633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auricle perniosis as a manifestation of Covid-19 infection.
    Proietti I; Tolino E; Bernardini N; Mambrin A; Balduzzi V; Marchesiello A; Michelini S; Del Borgo C; Skroza N; Lichtner M; Potenza C
    Dermatol Ther; 2020 Nov; 33(6):e14089. PubMed ID: 32720420
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous manifestation during COVID-19 pandemic.
    Galli E; Cipriani F; Ricci G; Maiello N
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):89-91. PubMed ID: 33236439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19.
    Demir B; Yuksel EI; Cicek D; Turkoglu S
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e551-e553. PubMed ID: 33987893
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 and seizures: Is there a link?
    Vohora D; Jain S; Tripathi M; Potschka H
    Epilepsia; 2020 Sep; 61(9):1840-1853. PubMed ID: 32944929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection.
    Yang Y; Hu X; Xiong L; Fu P; Feng W; Li W; Zhang L; Sun F
    BMC Infect Dis; 2021 Feb; 21(1):141. PubMed ID: 33535989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous signs in COVID-19 patients: A review.
    Wollina U; Karadağ AS; Rowland-Payne C; Chiriac A; Lotti T
    Dermatol Ther; 2020 Sep; 33(5):e13549. PubMed ID: 32390279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological findings in COVID-19-induced cutaneous lesions. Clinicopathological correlation of SARS-CoV-19 dermatologic patterns: review of the literature.
    Nieto-Benito LM; Hernández de la Torre-Ruiz E; Balaguer-Franch I; Rosell-Díaz ÁM; Mateos-Mayo A; Herrero-Sanchez A; Lacasta-Plasín C; García-Piqueras P; Barchino-Ortiz L; Bergón-Sendín M; Pulido-Pérez A; Baniandrés-Rodríguez O; Rodriguez-Lomba E; Molina-Lopez I; Suárez-Fernandez R
    Australas J Dermatol; 2021 Feb; 62(1):e98-e101. PubMed ID: 32920868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of nail findings associated with COVID-19 infection.
    Hadeler E; Morrison BW; Tosti A
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e699-e709. PubMed ID: 34131957
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal transplantation during the SARS-CoV-2 pandemic in the UK: Experience from a large-volume center.
    Georgiades F; Summers DM; Butler AJ; Russell NKI; Clatworthy MR; Torpey N
    Clin Transplant; 2021 Jan; 35(1):e14150. PubMed ID: 33170982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guillain-Barré syndrome associated with SARS-CoV-2].
    Chapon F
    Med Sci (Paris); 2020 Dec; 36 Hors série n° 2():53-54. PubMed ID: 33427637
    [No Abstract]   [Full Text] [Related]  

  • 20. Pneumomediastinum Related to Covid-19 Pneumonia.
    Romano N; Fischetti A; Melani EF
    Am J Med Sci; 2020 Dec; 360(6):e19-e20. PubMed ID: 32605714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.